Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-20 | New | $31,130,335 | $31,130,335 | Equity Only | 06b | SEC link |
| 2023-11-16 | New | $7,084,989 | $7,084,989 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Keith Loebner | Director |
| Huafeng Xu | Director, Executive |